These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38456579)

  • 1. Lifetime and 10-year cardiovascular risk prediction in individuals with type 1 diabetes: The LIFE-T1D model.
    Helmink MAG; Hageman SHJ; Eliasson B; Sattar N; Visseren FLJ; Dorresteijn JAN; Harris K; Peters SAE; Woodward M; Szentkúti P; Højlund K; Henriksen JE; Sørensen HT; Serné EH; van Sloten TT; Thomsen RW; Westerink J
    Diabetes Obes Metab; 2024 Jun; 26(6):2229-2238. PubMed ID: 38456579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of a lifetime prediction model for incident type 2 diabetes in patients with established cardiovascular disease: the CVD2DM model.
    Helmink MAG; Peters SAE; Westerink J; Harris K; Tillmann T; Woodward M; van Sloten TT; van der Meer MG; Teraa M; Dorresteijn JAN; Ruigrok YM; Visseren FLJ; Hageman SHJ;
    Eur J Prev Cardiol; 2024 Oct; 31(14):1671-1678. PubMed ID: 38584392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of First Cardiovascular Disease Event in Type 1 Diabetes Mellitus: The Steno Type 1 Risk Engine.
    Vistisen D; Andersen GS; Hansen CS; Hulman A; Henriksen JE; Bech-Nielsen H; Jørgensen ME
    Circulation; 2016 Mar; 133(11):1058-66. PubMed ID: 26888765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of individual life-years gained without cardiovascular events from lipid, blood pressure, glucose, and aspirin treatment based on data of more than 500 000 patients with Type 2 diabetes mellitus.
    Berkelmans GFN; Gudbjörnsdottir S; Visseren FLJ; Wild SH; Franzen S; Chalmers J; Davis BR; Poulter NR; Spijkerman AM; Woodward M; Pressel SL; Gupta AK; van der Schouw YT; Svensson AM; van der Graaf Y; Read SH; Eliasson B; Dorresteijn JAN
    Eur Heart J; 2019 Sep; 40(34):2899-2906. PubMed ID: 30629157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new model for 5-year risk of cardiovascular disease in Type 1 diabetes; from the Swedish National Diabetes Register (NDR).
    Cederholm J; Eeg-Olofsson K; Eliasson B; Zethelius B; Gudbjörnsdottir S;
    Diabet Med; 2011 Oct; 28(10):1213-20. PubMed ID: 21627687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a cardiovascular diseases risk prediction model and tools for Chinese patients with type 2 diabetes mellitus: A population-based retrospective cohort study.
    Wan EYF; Fong DYT; Fung CSC; Yu EYT; Chin WY; Chan AKC; Lam CLK
    Diabetes Obes Metab; 2018 Feb; 20(2):309-318. PubMed ID: 28722290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular health metrics defined by Life's Essential 8 scores and subsequent macrovascular and microvascular complications in individuals with type 2 diabetes: A prospective cohort study.
    Huang ZG; Gao JW; Zhang HF; You S; Xiong ZC; Wu YB; Guo DC; Wang JF; Chen YX; Zhang SL; Liu PM
    Diabetes Obes Metab; 2024 Jul; 26(7):2673-2683. PubMed ID: 38558498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of individual lifetime cardiovascular risk and potential treatment benefit: development and recalibration of the LIFE-CVD2 model to four European risk regions.
    Hageman SHJ; Kaptoge S; de Vries TI; Lu W; Kist JM; van Os HJA; Numans ME; Läll K; Bobak M; Pikhart H; Kubinova R; Malyutina S; Pająk A; Tamosiunas A; Erbel R; Stang A; Schmidt B; Schramm S; Bolton TR; Spackman S; Bakker SJL; Blaha M; Boer JMA; Bonnefond A; Brenner H; Brunner EJ; Cook NR; Davidson K; Dennison E; Donfrancesco C; Dörr M; Floyd JS; Ford I; Fu M; Gansevoort RT; Giampaoli S; Gillum RF; Gómez-de-la-Cámara A; Håheim LL; Hansson PO; Harms P; Humphries SE; Ikram MK; Jukema JW; Kavousi M; Kiechl S; Kucharska-Newton A; Pablos DL; Matsushita K; Meyer HE; Moons KGM; Mortensen MB; Muilwijk M; Nordestgaard BG; Packard C; Pamieri L; Panagiotakos D; Peters A; Potier L; Providencia R; Psaty BM; Ridker PM; Rodriguez B; Rosengren A; Sattar N; Schöttker B; Schwartz JE; Shea S; Shipley MJ; Sofat R; Thorand B; Verschuren WMM; Völzke H; Wareham NJ; Westbury L; Willeit P; Zhou B; Danesh J; Visseren FLJ; Di Angelantonio E; Pennells L; Dorresteijn JAN
    Eur J Prev Cardiol; 2024 Oct; 31(14):1690-1699. PubMed ID: 38752762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association of low-density lipoprotein cholesterol with elevated arterial stiffness in adolescents and young adults with type 1 and type 2 diabetes: The SEARCH for Diabetes in Youth study.
    Gourgari E; Stafford JM; D'Agostino R; Dolan LM; Lawrence JM; Marcovina S; Merjaneh L; Mottl AK; Shah AS; Dabelea D
    Pediatr Diabetes; 2020 Aug; 21(5):863-870. PubMed ID: 32304144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of QDiabetes-2018 risk prediction algorithm to estimate future risk of type 2 diabetes: cohort study.
    Hippisley-Cox J; Coupland C
    BMJ; 2017 Nov; 359():j5019. PubMed ID: 29158232
    [No Abstract]   [Full Text] [Related]  

  • 11. Risk Factors for Cardiovascular Disease (CVD) in Adults with Type 1 Diabetes: Findings from Prospective Real-life T1D Exchange Registry.
    Shah VN; Bailey R; Wu M; Foster NC; Pop-Busui R; Katz M; Crandall J; Bacha F; Nadeau K; Libman I; Hiers P; Mizokami-Stout K; DiMeglio LA; Sherr J; Pratley R; Agarwal S; Snell-Bergeon J; Cengiz E; Polsky S; Mehta SN
    J Clin Endocrinol Metab; 2020 May; 105(5):e2032-8. PubMed ID: 31955209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SCORE2-Diabetes: 10-year cardiovascular risk estimation in type 2 diabetes in Europe.
    SCORE2-Diabetes Working Group and the ESC Cardiovascular Risk Collaboration
    Eur Heart J; 2023 Jul; 44(28):2544-2556. PubMed ID: 37247330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Association of Severe Diabetic Retinopathy With Cardiovascular Outcomes in Long-standing Type 1 Diabetes: A Longitudinal Follow-up.
    Pongrac Barlovic D; Harjutsalo V; Gordin D; Kallio M; Forsblom C; King G; Groop PH;
    Diabetes Care; 2018 Dec; 41(12):2487-2494. PubMed ID: 30257963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycemic control and cardiovascular disease in 7,454 patients with type 1 diabetes: an observational study from the Swedish National Diabetes Register (NDR).
    Eeg-Olofsson K; Cederholm J; Nilsson PM; Zethelius B; Svensson AM; Gudbjörnsdóttir S; Eliasson B
    Diabetes Care; 2010 Jul; 33(7):1640-6. PubMed ID: 20424222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of Microvascular Complications and Effect of Concurrent Risk Factors in Type 1 Diabetes: A Multistate Model From an Observational Clinical Cohort Study.
    Bjerg L; Hulman A; Carstensen B; Charles M; Jørgensen ME; Witte DR
    Diabetes Care; 2018 Nov; 41(11):2297-2305. PubMed ID: 30131399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and Validation of the American Heart Association's PREVENT Equations.
    Khan SS; Matsushita K; Sang Y; Ballew SH; Grams ME; Surapaneni A; Blaha MJ; Carson AP; Chang AR; Ciemins E; Go AS; Gutierrez OM; Hwang SJ; Jassal SK; Kovesdy CP; Lloyd-Jones DM; Shlipak MG; Palaniappan LP; Sperling L; Virani SS; Tuttle K; Neeland IJ; Chow SL; Rangaswami J; Pencina MJ; Ndumele CE; Coresh J;
    Circulation; 2024 Feb; 149(6):430-449. PubMed ID: 37947085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obesity paradox in people newly diagnosed with type 2 diabetes with and without prior cardiovascular disease.
    Thomas G; Khunti K; Curcin V; Molokhia M; Millett C; Majeed A; Paul S
    Diabetes Obes Metab; 2014 Apr; 16(4):317-25. PubMed ID: 24118783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of cardiovascular disease and its associated risk factors in at-risk men and women in the United Arab Emirates: a 9-year retrospective cohort study.
    Al-Shamsi S; Regmi D; Govender RD
    BMC Cardiovasc Disord; 2019 Jun; 19(1):148. PubMed ID: 31208354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of Five-Year Cardiovascular Disease Risk in People with Type 2 Diabetes Mellitus: Derivation in Nanjing, China and External Validation in Scotland, UK.
    Wan C; Read S; Wu H; Lu S; Zhang X; Wild SH; Liu Y
    Glob Heart; 2022; 17(1):46. PubMed ID: 36051323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of future microvascular and macrovascular disease in people with Type 1 diabetes of very long duration: a national study with 10-year follow-up.
    Adamsson Eryd S; Svensson AM; Franzén S; Eliasson B; Nilsson PM; Gudbjörnsdottir S
    Diabet Med; 2017 Mar; 34(3):411-418. PubMed ID: 27647178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.